Tenon Medical
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 21
- Market Cap
- -
- Introduction
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
- Conditions
- Sacroiliac Joint DisruptionDegenerative Sacroiliitis
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Tenon Medical
- Target Recruit Count
- 50
- Registration Number
- NCT05633888
- Locations
- 🇺🇸
Northwest Specialty Hospital, Coeur d'Alene, Idaho, United States
🇺🇸Comprehensive Pain and Spine Specialists, Muncie, Indiana, United States
🇺🇸Vitality Pain Centers, Louisville, Kentucky, United States
Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study
- Conditions
- Degenerative SacroiliitisSacroiliac Joint Disruption
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Tenon Medical
- Target Recruit Count
- 50
- Registration Number
- NCT05628142
- Locations
- 🇺🇸
Minimally Invasive Neurosurgery of Texas, Plano, Texas, United States
🇺🇸St. George Orthopaedic Spine, Saint George, Utah, United States
News
Tenon Medical's Catamaran SI Joint Fusion System Shows 83% Fusion Rate and Significant Pain Reduction at 12 Months
Tenon Medical's MAINSAIL study demonstrates statistically significant pain reduction from 78.8mm to 23.0mm on VAS scale and disability improvement from 51.6% to 20.8% on ODI scale at 12 months (p<0.001).
Tenon Medical Launches Catamaran SE SI Joint Fusion System with Reduced Profile Design
Tenon Medical announced the full commercial launch of its Catamaran SE SI Joint Fusion System, featuring a reduced profile design compared to the original device.
FDA Expands Tenon Medical's Catamaran System Indication for Thoracolumbar Fusion Augmentation
The FDA has granted Tenon Medical clearance for an expanded indication of its Catamaran SI Joint Fusion System to augment thoracolumbar fusion, beyond its original standalone treatment purpose.
Tenon Medical Secures $3.0 Million Through Warrant Transaction to Advance SI Joint Fusion Technology
Tenon Medical has secured $3.0 million in gross proceeds through a warrant inducement agreement with an existing healthcare-focused institutional investor at a reduced exercise price of $1.25 per share.